Risks of cholesterol-lowering therapies
- 1 October 1996
- journal article
- other
- Published by Elsevier in Biological Psychiatry
- Vol. 40 (7) , 686-687
- https://doi.org/10.1016/0006-3223(96)00173-4
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Brain serotonin (5-HT) neuroendocrine function in patients taking cholesterol-lowering drugsBiological Psychiatry, 1996
- Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfyThe American Journal of Clinical Nutrition, 1995
- Associations of cholesterol lowering by statins with anger and hostility in hypercholesterolemic menBiological Psychiatry, 1994
- Effect of simvastatin and fenofibrate on the fatty acid composition of hypercholesterolaemic patients.British Journal of Clinical Pharmacology, 1991
- Rhodopsin in dimyristoylphosphatidylcholine-reconstituted bilayers forms metarhodopsin II and activates GtBiochemistry, 1991